Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Fresh cut Cantaloupe products recalled due to Salmonella


OTTAWA, ON, Dec. 1, 2023 /CNW/ - 

Product: Fresh Cut Cantaloupe Products 
Issue: Food - Microbial Contamination - Salmonella
Distribution: British Columbia

See the affected products and product photos for this recall

Company information

Frankly Fresh Salads Inc. 

Telephone: 604 255-0054

Public enquiries

Toll-free: 1-800-442-2342 (Canada and U.S.)

Telephone: 1-613-773-2342 (local or international)

Email: [email protected]

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 08:30
Toitures Hogue becomes the only company in its sector in Quebec to receive international ISO-45001 health & safety recertification
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
Anti-Mullerian Hormone Test Market Projected to Reach $586.48 million by 2030 - Exclusive Report by 360iResearch
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
Greenberg Traurig's David Dykeman and Roman Fayerberg to Present at DeviceTalks Boston
David J. Dykeman, co-chair of the Life Sciences & Medical...

More news about Health...


News published on and distributed by: